ID   CFTR_MOUSE              Reviewed;        1476 AA.
AC   P26361; Q63893; Q63894; Q9JKQ6;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   18-JUN-2025, entry version 223.
DE   RecName: Full=Cystic fibrosis transmembrane conductance regulator {ECO:0000305};
DE            Short=CFTR;
DE   AltName: Full=ATP-binding cassette sub-family C member 7;
DE   AltName: Full=Channel conductance-controlling ATPase;
DE            EC=5.6.1.6 {ECO:0000250|UniProtKB:P13569};
DE   AltName: Full=cAMP-dependent chloride channel;
GN   Name=Cftr {ECO:0000312|MGI:MGI:88388}; Synonyms=Abcc7;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1712752; DOI=10.1016/0888-7543(91)90312-3;
RA   Tata F., Stanier P., Wicking C., Halford S., Kruyer H., Lench N.J.,
RA   Scambler P.J., Hansen C., Braman J.C., Williamson R., Wainwright B.J.;
RT   "Cloning the mouse homolog of the human cystic fibrosis transmembrane
RT   conductance regulator gene.";
RL   Genomics 10:301-307(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ;
RX   PubMed=1716243; DOI=10.1016/0888-7543(91)90434-g;
RA   Yorifuji T., Lemna W.K., Ballard C.F., Rosenbloom C.L., Rozmahel R.,
RA   Plavsic N., Tsui L.-C., Beaudet A.L.;
RT   "Molecular cloning and sequence analysis of the murine cDNA for the cystic
RT   fibrosis transmembrane conductance regulator.";
RL   Genomics 10:547-550(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10655503; DOI=10.1073/pnas.97.3.1172;
RA   Ellsworth R.E., Jamison D.C., Touchman J.W., Chissoe S.L.,
RA   Braden Maduro V.V., Bouffard G.G., Dietrich N.L., Beckstrom-Sternberg S.M.,
RA   Iyer L.M., Weintraub L.A., Cotton M., Courtney L., Edwards J., Maupin R.,
RA   Ozersky P., Rohlfing T., Wohldmann P., Miner T., Kemp K., Kramer J.,
RA   Korf I., Pepin K., Antonacci-Fulton L., Fulton R.S., Minx P., Hillier L.W.,
RA   Wilson R.K., Waterston R.H., Miller W., Green E.D.;
RT   "Comparative genomic sequence analysis of the human and mouse cystic
RT   fibrosis transmembrane conductance regulator genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1172-1177(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-17.
RX   PubMed=7526924; DOI=10.1093/hmg/3.7.1089;
RA   Denamur E., Chehab F.F.;
RT   "Analysis of the mouse and rat CFTR promoter regions.";
RL   Hum. Mol. Genet. 3:1089-1094(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 549-600, ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=7691356; DOI=10.1038/ng0893-426;
RA   Delaney S.J., Rich D.P., Thomson S.A., Hargrave M.R., Lovelock P.K.,
RA   Welsh M.J., Wainwright B.J.;
RT   "Cystic fibrosis transmembrane conductance regulator splice variants are
RT   not conserved and fail to produce chloride channels.";
RL   Nat. Genet. 4:426-431(1993).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=7685652; DOI=10.1038/ng0593-35;
RA   Ratcliff R., Evans M.J., Cuthbert A.W., MacVinish L.J., Foster D.,
RA   Anderson J.R., Colledge W.H.;
RT   "Production of a severe cystic fibrosis mutation in mice by gene
RT   targeting.";
RL   Nat. Genet. 4:35-41(1993).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH AHCYL1.
RX   PubMed=19033647; DOI=10.1172/jci36983;
RA   Yang D., Shcheynikov N., Zeng W., Ohana E., So I., Ando H., Mizutani A.,
RA   Mikoshiba K., Muallem S.;
RT   "IRBIT coordinates epithelial fluid and HCO3- secretion by stimulating the
RT   transporters pNBC1 and CFTR in the murine pancreatic duct.";
RL   J. Clin. Invest. 119:193-202(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-698 AND SER-790, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   FUNCTION, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=20231442; DOI=10.1073/pnas.0902661107;
RA   Lu M., Dong K., Egan M.E., Giebisch G.H., Boulpaep E.L., Hebert S.C.;
RT   "Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-
RT   regulated apical chloride channels in cortical collecting duct.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:6082-6087(2010).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SLC26A3; SLC26A6 AND NHERF1.
RX   PubMed=21976599; DOI=10.1095/biolreprod.111.094037;
RA   Chavez J.C., Hernandez-Gonzalez E.O., Wertheimer E., Visconti P.E.,
RA   Darszon A., Trevino C.L.;
RT   "Participation of the Cl-/HCO(3)- exchangers SLC26A3 and SLC26A6, the
RT   Cl- channel CFTR, and the regulatory factor SLC9A3R1 in mouse sperm
RT   capacitation.";
RL   Biol. Reprod. 86:1-14(2012).
RN   [11]
RP   INTERACTION WITH AHCYL1.
RX   PubMed=23542070; DOI=10.1053/j.gastro.2013.03.047;
RA   Park S., Shcheynikov N., Hong J.H., Zheng C., Suh S.H., Kawaai K., Ando H.,
RA   Mizutani A., Abe T., Kiyonari H., Seki G., Yule D., Mikoshiba K.,
RA   Muallem S.;
RT   "Irbit mediates synergy between ca(2+) and cAMP signaling pathways during
RT   epithelial transport in mice.";
RL   Gastroenterology 145:232-241(2013).
RN   [12]
RP   FUNCTION.
RX   PubMed=26823428; DOI=10.1126/science.aad5589;
RA   Shah V.S., Meyerholz D.K., Tang X.X., Reznikov L., Abou Alaiwa M.,
RA   Ernst S.E., Karp P.H., Wohlford-Lenane C.L., Heilmann K.P., Leidinger M.R.,
RA   Allen P.D., Zabner J., McCray P.B. Jr., Ostedgaard L.S., Stoltz D.A.,
RA   Randak C.O., Welsh M.J.;
RT   "Airway acidification initiates host defense abnormalities in cystic
RT   fibrosis mice.";
RL   Science 351:503-507(2016).
RN   [13]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF PHE-508.
RX   PubMed=21884936; DOI=10.1016/j.cell.2011.07.021;
RA   Gee H.Y., Noh S.H., Tang B.L., Kim K.H., Lee M.G.;
RT   "Rescue of DeltaF508-CFTR trafficking via a GRASP-dependent unconventional
RT   secretion pathway.";
RL   Cell 146:746-760(2011).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=30659401; DOI=10.1007/s10735-019-09813-3;
RA   Sharma S., Hanukoglu I.;
RT   "Mapping the sites of localization of epithelial sodium channel (ENaC) and
RT   CFTR in segments of the mammalian epididymis.";
RL   J. Mol. Histol. 50:141-154(2019).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 389-673 IN COMPLEXES WITH ATP AND
RP   ATP ANALOGS, AND DOMAIN.
RX   PubMed=14685259; DOI=10.1038/sj.emboj.7600040;
RA   Lewis H.A., Buchanan S.G., Burley S.K., Conners K., Dickey M., Dorwart M.,
RA   Fowler R., Gao X., Guggino W.B., Hendrickson W.A., Hunt J.F., Kearins M.C.,
RA   Lorimer D., Maloney P.C., Post K.W., Rajashankar K.R., Rutter M.E.,
RA   Sauder J.M., Shriver S., Thibodeau P.H., Thomas P.J., Zhang M., Zhao X.,
RA   Emtage S.;
RT   "Structure of nucleotide-binding domain 1 of the cystic fibrosis
RT   transmembrane conductance regulator.";
RL   EMBO J. 23:282-293(2004).
RN   [16] {ECO:0007744|PDB:1XF9, ECO:0007744|PDB:1XFA}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 389-670 IN COMPLEX WITH ATP,
RP   DOMAIN, AND MUTAGENESIS OF PHE-508.
RX   PubMed=15619636; DOI=10.1038/nsmb881;
RA   Thibodeau P.H., Brautigam C.A., Machius M., Thomas P.J.;
RT   "Side chain and backbone contributions of Phe508 to CFTR folding.";
RL   Nat. Struct. Mol. Biol. 12:10-16(2005).
RN   [17] {ECO:0007744|PDB:3SI7}
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 389-673 IN COMPLEX WITH ATP AND
RP   MAGNESIUM, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF PHE-508.
RX   PubMed=22265409; DOI=10.1016/j.cell.2011.11.023;
RA   Mendoza J.L., Schmidt A., Li Q., Nuvaga E., Barrett T., Bridges R.J.,
RA   Feranchak A.P., Brautigam C.A., Thomas P.J.;
RT   "Requirements for efficient correction of F508 CFTR revealed by analyses of
RT   evolved sequences.";
RL   Cell 148:164-174(2012).
CC   -!- FUNCTION: Epithelial ion channel that plays an important role in the
CC       regulation of epithelial ion and water transport and fluid homeostasis
CC       (PubMed:26823428). Mediates the transport of chloride ions across the
CC       cell membrane (PubMed:20231442, PubMed:22265409). Possesses an
CC       intrinsic ATPase activity and utilizes ATP to gate its channel; the
CC       passive flow of anions through the channel is gated by cycles of ATP
CC       binding and hydrolysis by the ATP-binding domains (By similarity). The
CC       ion channel is also permeable to HCO(3)(-); selectivity depends on the
CC       extracellular chloride concentration. Exerts its function also by
CC       modulating the activity of other ion channels and transporters.
CC       Contributes to the regulation of the pH and the ion content of the
CC       epithelial fluid layer. Modulates the activity of the epithelial sodium
CC       channel (ENaC) complex, in part by regulating the cell surface
CC       expression of the ENaC complex. May regulate bicarbonate secretion and
CC       salvage in epithelial cells by regulating the transporter SLC4A7. Can
CC       inhibit the chloride channel activity of ANO1 (By similarity). Plays a
CC       role in the chloride and bicarbonate homeostasis during sperm
CC       epididymal maturation and capacitation (PubMed:21976599).
CC       {ECO:0000250|UniProtKB:P13569, ECO:0000269|PubMed:19033647,
CC       ECO:0000269|PubMed:20231442, ECO:0000269|PubMed:21976599,
CC       ECO:0000269|PubMed:22265409, ECO:0000269|PubMed:26823428}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + closed Cl(-) channel = ADP + phosphate + open
CC         Cl(-) channel.; EC=5.6.1.6; Evidence={ECO:0000250|UniProtKB:P13569};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000250|UniProtKB:P13569};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hydrogencarbonate(in) = hydrogencarbonate(out);
CC         Xref=Rhea:RHEA:28695, ChEBI:CHEBI:17544;
CC         Evidence={ECO:0000250|UniProtKB:P13569};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P13569};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13066;
CC         Evidence={ECO:0000250|UniProtKB:P13569};
CC   -!- SUBUNIT: Monomer; does not require oligomerization for channel
CC       activity. May form oligomers in the membrane (By similarity). Interacts
CC       with SLC26A3, SLC26A6 and NHERF1 (PubMed:21976599). Interacts with
CC       SHANK2 (By similarity). Interacts with MYO6 (By similarity). Interacts
CC       (via C-terminus) with GOPC (via PDZ domain); this promotes CFTR
CC       internalization and thereby decreases channel activity. Interacts with
CC       SLC4A7 through NHERF1. Found in a complex with MYO5B and RAB11A.
CC       Interacts with ANO1. Interacts with SLC26A8 (By similarity). Interacts
CC       with AHCYL1; the interaction increases CFTR activity (PubMed:19033647,
CC       PubMed:23542070). Interacts with CSE1L (By similarity). The core-
CC       glycosylated form interacts with GORASP2 (via PDZ GRASP-type 1 domain)
CC       in respone to ER stress (By similarity). Interacts with MARCHF2; the
CC       interaction leads to CFTR ubiqtuitination and degradation (By
CC       similarity). Interacts with ADGRG2 (By similarity).
CC       {ECO:0000250|UniProtKB:P13569, ECO:0000250|UniProtKB:P34158,
CC       ECO:0000269|PubMed:19033647, ECO:0000269|PubMed:21976599,
CC       ECO:0000269|PubMed:23542070}.
CC   -!- INTERACTION:
CC       P26361; P70441: Nherf1; NbExp=3; IntAct=EBI-6115317, EBI-1184085;
CC       P26361; Q9WVC8: Slc26a3; NbExp=3; IntAct=EBI-6115317, EBI-6895537;
CC       P26361; Q8CIW6: Slc26a6; NbExp=3; IntAct=EBI-6115317, EBI-6895517;
CC       P26361; P19120: HSPA8; Xeno; NbExp=5; IntAct=EBI-6115317, EBI-907802;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:20231442, ECO:0000269|PubMed:21884936}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:P13569}. Early endosome
CC       membrane {ECO:0000250|UniProtKB:P13569}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P13569}. Cell membrane
CC       {ECO:0000269|PubMed:20231442, ECO:0000269|PubMed:22265409}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:P13569}. Recycling endosome
CC       membrane {ECO:0000250|UniProtKB:P13569}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P13569}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P13569}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P13569}. Nucleus {ECO:0000250|UniProtKB:P34158}.
CC       Note=The channel is internalized from the cell surface into an
CC       endosomal recycling compartment, from where it is recycled to the cell
CC       membrane. In the oviduct and bronchus, detected on the apical side of
CC       epithelial cells, but not associated with cilia. In Sertoli cells, a
CC       processed product is detected in the nucleus. ER stress induces
CC       GORASP2-mediated unconventional (ER/Golgi-independent) trafficking of
CC       core-glycosylated CFTR to cell membrane (PubMed:21884936).
CC       {ECO:0000250|UniProtKB:P13569, ECO:0000250|UniProtKB:P34158,
CC       ECO:0000269|PubMed:21884936}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P26361-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P26361-2; Sequence=VSP_000062, VSP_000063;
CC       Name=3;
CC         IsoId=P26361-3; Sequence=VSP_000064, VSP_000065;
CC   -!- TISSUE SPECIFICITY: Expressed in the epididymis (at protein level)
CC       (PubMed:30659401). In the initial segment of the epididymis, detected
CC       on both the luminal and basolateral sides of the ducts where it is
CC       expressed in the duct columnar cells as well as in the interstitial
CC       smooth muscle cells (PubMed:30659401). Expressed in sperm in the caput
CC       (PubMed:30659401). In the cauda, detected along the luminal border but
CC       not continuously and is also expressed on the basolateral surface
CC       (PubMed:30659401). Within the caudal lumen, detected on sperm
CC       (PubMed:30659401). Isoform 1: Expressed in a variety of epithelial
CC       tissues including colon, kidney, lung, small intestine, pancreatic duct
CC       and testis (PubMed:7691356). Isoform 2: Expressed only in testis
CC       (PubMed:7691356). Isoform 3: Expressed only in testis (PubMed:7691356).
CC       {ECO:0000269|PubMed:30659401, ECO:0000269|PubMed:7691356}.
CC   -!- DOMAIN: Binds and hydrolyzes ATP via the two cytoplasmic ABC
CC       transporter nucleotide-binding domains. The two ATP-binding domains
CC       interact with each other, forming a head-to-tail dimer. Normal ATPase
CC       activity requires interaction between the two domains (By similarity).
CC       The first ABC transporter nucleotide-binding domain has no ATPase
CC       activity by itself (PubMed:14685259, PubMed:15619636).
CC       {ECO:0000250|UniProtKB:P13569, ECO:0000269|PubMed:14685259,
CC       ECO:0000269|PubMed:15619636}.
CC   -!- DOMAIN: The PDZ-binding motif mediates interactions with GOPC and with
CC       the SLC4A7, NHERF1/EBP50 complex. {ECO:0000250|UniProtKB:P13569}.
CC   -!- DOMAIN: The disordered R region mediates channel activation when it is
CC       phosphorylated, but not in the absence of phosphorylation.
CC       {ECO:0000250|UniProtKB:P13569}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P13569}.
CC   -!- PTM: Phosphorylated; cAMP treatment promotes phosphorylation and
CC       activates the channel. Dephosphorylation decreases the ATPase activity
CC       (in vitro). Phosphorylation at PKA sites activates the channel.
CC       Phosphorylation at PKC sites enhances the response to phosphorylation
CC       by PKA. Phosphorylated by AMPK; this inhibits channel activity.
CC       {ECO:0000250|UniProtKB:P13569}.
CC   -!- PTM: Ubiquitinated, leading to its degradation in the lysosome.
CC       Deubiquitination by USP10 in early endosomes enhances its endocytic
CC       recycling to the cell membrane. Ubiquitinated by RNF185 during ER
CC       stress. Ubiquitinated by MARCHF2 (By similarity).
CC       {ECO:0000250|UniProtKB:P13569}.
CC   -!- DISRUPTION PHENOTYPE: Mice are born at the expected Mendelian rate, but
CC       about 80% die within two to five days after birth due to peritonitis
CC       (PubMed:7685652). Those that survive fail to thrive, appear runted and
CC       weigh about half as much as wild-type littermates (PubMed:7685652).
CC       Many of the surviving pups die when they start ingesting solid food,
CC       due to intestinal blockage caused by excessive mucus accumulation
CC       (PubMed:7685652). None survive for more than about 45 days after birth
CC       (PubMed:7685652). Intestinal crypts in the jejunum and ileum are filled
CC       with excessive mucus (PubMed:7685652). Excessive accumulation of mucus
CC       is also seen in colon (PubMed:7685652). In contrast, their lungs do not
CC       present pathological mucus accumulation (PubMed:7685652). Likewise,
CC       only five out of ten animals show dilatation and blockage of several
CC       small pancreatic ducts (PubMed:7685652). Besides, mutant mice present
CC       defects in their lacrimal glands that make them more susceptible to
CC       develop eye infections (PubMed:7685652). In caecum epithelium,
CC       forskolin-sensitive ion transport is nearly abolished (PubMed:7685652).
CC       {ECO:0000269|PubMed:7685652}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC family.
CC       CFTR transporter (TC 3.A.1.202) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M69298; AAA37417.1; -; mRNA.
DR   EMBL; M60493; AAA18903.1; -; mRNA.
DR   EMBL; AF162137; AAF30300.1; -; Genomic_DNA.
DR   EMBL; L04873; AAA73562.1; -; Genomic_DNA.
DR   EMBL; S65942; AAB28393.1; -; Genomic_DNA.
DR   EMBL; S65940; AAB28393.1; JOINED; Genomic_DNA.
DR   EMBL; S65941; AAB28393.1; JOINED; Genomic_DNA.
DR   EMBL; S65942; AAB28391.1; -; Genomic_DNA.
DR   EMBL; S65941; AAB28392.1; -; Genomic_DNA.
DR   EMBL; S65940; AAB28392.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS19930.1; -. [P26361-1]
DR   PIR; A39901; A39901.
DR   PIR; A40303; A40303.
DR   PIR; I49593; I49593.
DR   PIR; I58115; I58115.
DR   PIR; I78527; I78527.
DR   RefSeq; NP_066388.1; NM_021050.2. [P26361-1]
DR   RefSeq; XP_006505040.1; XM_006504977.1.
DR   RefSeq; XP_006505041.1; XM_006504978.1.
DR   PDB; 1Q3H; X-ray; 2.50 A; A/B/C/D=389-673.
DR   PDB; 1R0W; X-ray; 2.20 A; A/B/C/D=389-673.
DR   PDB; 1R0X; X-ray; 2.20 A; A/B/C/D=389-673.
DR   PDB; 1R0Y; X-ray; 2.55 A; A/B/C/D=389-673.
DR   PDB; 1R0Z; X-ray; 2.35 A; A/B/C/D=389-673.
DR   PDB; 1R10; X-ray; 3.00 A; A/B=389-673.
DR   PDB; 1XF9; X-ray; 2.70 A; A/B/C/D=389-670.
DR   PDB; 1XFA; X-ray; 3.10 A; A/B=389-670.
DR   PDB; 3SI7; X-ray; 2.25 A; A/B/C/D=389-673.
DR   PDBsum; 1Q3H; -.
DR   PDBsum; 1R0W; -.
DR   PDBsum; 1R0X; -.
DR   PDBsum; 1R0Y; -.
DR   PDBsum; 1R0Z; -.
DR   PDBsum; 1R10; -.
DR   PDBsum; 1XF9; -.
DR   PDBsum; 1XFA; -.
DR   PDBsum; 3SI7; -.
DR   AlphaFoldDB; P26361; -.
DR   SMR; P26361; -.
DR   BioGRID; 198687; 12.
DR   CORUM; P26361; -.
DR   DIP; DIP-29618N; -.
DR   FunCoup; P26361; 387.
DR   IntAct; P26361; 11.
DR   MINT; P26361; -.
DR   STRING; 10090.ENSMUSP00000049228; -.
DR   GlyCosmos; P26361; 2 sites, No reported glycans.
DR   GlyGen; P26361; 2 sites.
DR   iPTMnet; P26361; -.
DR   PhosphoSitePlus; P26361; -.
DR   PaxDb; 10090-ENSMUSP00000049228; -.
DR   PeptideAtlas; P26361; -.
DR   ProteomicsDB; 281397; -. [P26361-1]
DR   ProteomicsDB; 281398; -. [P26361-2]
DR   ProteomicsDB; 281399; -. [P26361-3]
DR   Antibodypedia; 4530; 1170 antibodies from 41 providers.
DR   DNASU; 12638; -.
DR   Ensembl; ENSMUST00000045706.12; ENSMUSP00000049228.6; ENSMUSG00000041301.16. [P26361-1]
DR   Ensembl; ENSMUST00000115405.9; ENSMUSP00000111064.3; ENSMUSG00000041301.16. [P26361-3]
DR   Ensembl; ENSMUST00000140407.8; ENSMUSP00000116957.2; ENSMUSG00000041301.16. [P26361-2]
DR   GeneID; 12638; -.
DR   KEGG; mmu:12638; -.
DR   UCSC; uc009bai.1; mouse. [P26361-1]
DR   AGR; MGI:88388; -.
DR   CTD; 1080; -.
DR   MGI; MGI:88388; Cftr.
DR   VEuPathDB; HostDB:ENSMUSG00000041301; -.
DR   eggNOG; KOG0054; Eukaryota.
DR   GeneTree; ENSGT00940000158567; -.
DR   HOGENOM; CLU_000604_27_14_1; -.
DR   InParanoid; P26361; -.
DR   OMA; CQRYLVI; -.
DR   OrthoDB; 6500128at2759; -.
DR   PhylomeDB; P26361; -.
DR   BRENDA; 2.7.4.3; 3474.
DR   BRENDA; 5.6.1.6; 3474.
DR   Reactome; R-MMU-382556; ABC-family proteins mediated transport.
DR   Reactome; R-MMU-5627083; RHO GTPases regulate CFTR trafficking.
DR   Reactome; R-MMU-5689880; Ub-specific processing proteases.
DR   Reactome; R-MMU-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-MMU-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-MMU-9013406; RHOQ GTPase cycle.
DR   Reactome; R-MMU-9646399; Aggrephagy.
DR   BioGRID-ORCS; 12638; 4 hits in 77 CRISPR screens.
DR   ChiTaRS; Cftr; mouse.
DR   EvolutionaryTrace; P26361; -.
DR   PRO; PR:P26361; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; P26361; protein.
DR   Bgee; ENSMUSG00000041301; Expressed in paneth cell and 107 other cell types or tissues.
DR   ExpressionAtlas; P26361; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071889; F:14-3-3 protein binding; IEA:Ensembl.
DR   GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; ISS:UniProtKB.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0019869; F:chloride channel inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0015108; F:chloride transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0005260; F:intracellularly ATP-gated chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IEA:Ensembl.
DR   GO; GO:0106138; F:Sec61 translocon complex binding; IEA:Ensembl.
DR   GO; GO:0097186; P:amelogenesis; IDA:ARUK-UCL.
DR   GO; GO:0015701; P:bicarbonate transport; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IGI:MGI.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IMP:MGI.
DR   GO; GO:0030301; P:cholesterol transport; IMP:MGI.
DR   GO; GO:0051649; P:establishment of localization in cell; IGI:MGI.
DR   GO; GO:0051454; P:intracellular pH elevation; IMP:UniProtKB.
DR   GO; GO:0060081; P:membrane hyperpolarization; IMP:UniProtKB.
DR   GO; GO:0050891; P:multicellular organismal-level water homeostasis; ISS:UniProtKB.
DR   GO; GO:1902161; P:positive regulation of cyclic nucleotide-gated ion channel activity; IMP:UniProtKB.
DR   GO; GO:0070175; P:positive regulation of enamel mineralization; IDA:ARUK-UCL.
DR   GO; GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0048240; P:sperm capacitation; IMP:UniProtKB.
DR   GO; GO:0035377; P:transepithelial water transport; ISS:UniProtKB.
DR   GO; GO:0006904; P:vesicle docking involved in exocytosis; IMP:UniProtKB.
DR   CDD; cd03291; ABCC_CFTR1; 1.
DR   CDD; cd03289; ABCC_CFTR2; 1.
DR   FunFam; 1.20.1560.10:FF:000017; Cystic fibrosis transmembrane conductance regulator; 1.
DR   FunFam; 1.20.1560.10:FF:000019; Cystic fibrosis transmembrane conductance regulator; 1.
DR   FunFam; 3.40.50.300:FF:000581; Cystic fibrosis transmembrane conductance regulator; 1.
DR   FunFam; 3.40.50.300:FF:000591; Cystic fibrosis transmembrane conductance regulator; 1.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR050173; ABC_transporter_C-like.
DR   InterPro; IPR009147; CFTR/ABCC7.
DR   InterPro; IPR047082; CFTR1_ATP-bd_dom1.
DR   InterPro; IPR025837; CFTR_reg_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR01271; CFTR_protein; 1.
DR   PANTHER; PTHR24223; ATP-BINDING CASSETTE SUB-FAMILY C; 1.
DR   PANTHER; PTHR24223:SF19; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   Pfam; PF14396; CFTR_R; 1.
DR   PRINTS; PR01851; CYSFIBREGLTR.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
DR   TreeFam; TF105200; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; Chloride;
KW   Chloride channel; Endoplasmic reticulum; Endosome; Glycoprotein;
KW   Ion channel; Ion transport; Isomerase; Lipoprotein; Membrane;
KW   Nucleotide-binding; Nucleus; Palmitate; Phosphoprotein; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN           1..1476
FT                   /note="Cystic fibrosis transmembrane conductance regulator"
FT                   /id="PRO_0000093424"
FT   TOPO_DOM        1..77
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        78..98
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        99..122
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        123..146
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        147..195
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        196..216
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        217..222
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        223..243
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        244..298
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        299..319
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        320..339
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        340..358
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        359..853
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        854..874
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        875..913
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        914..934
FT                   /note="Discontinuously helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        935..985
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        986..1006
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        1007..1008
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        1009..1029
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        1030..1090
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        1091..1111
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        1112..1125
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TRANSMEM        1126..1146
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   TOPO_DOM        1147..1476
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   DOMAIN          81..365
FT                   /note="ABC transmembrane type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          423..646
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          854..1153
FT                   /note="ABC transmembrane type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          1208..1439
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          654..826
FT                   /note="Disordered R region"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   REGION          1382..1476
FT                   /note="Interaction with GORASP2"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   REGION          1446..1476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1474..1476
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   COMPBIAS        1466..1476
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         401
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   BINDING         458..465
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434,
FT                   ECO:0007744|PDB:1Q3H, ECO:0007744|PDB:1R0X,
FT                   ECO:0007744|PDB:1R0Z, ECO:0007744|PDB:1R10,
FT                   ECO:0007744|PDB:1XF9, ECO:0007744|PDB:1XFA,
FT                   ECO:0007744|PDB:3SI7"
FT   BINDING         493
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0007744|PDB:1Q3H, ECO:0007744|PDB:1R0X,
FT                   ECO:0007744|PDB:1R0Z, ECO:0007744|PDB:1XFA"
FT   BINDING         1215
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   BINDING         1240..1247
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   MOD_RES         549
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         660
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         670
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         698
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         710
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         715
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         732
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         763
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         785
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         790
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         808
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         1440
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   MOD_RES         1452
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   LIPID           524
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   LIPID           1391
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P13569"
FT   CARBOHYD        889
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        895
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         561..600
FT                   /note="AVYKDADLYLLDSPFGYLDVFTEEQVFESCVCKLMANKTR -> QRTRSPYL
FT                   EIRIFLCLFLYTRMKVCATTPEQYIKMLICTY (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000064"
FT   VAR_SEQ         561..576
FT                   /note="AVYKDADLYLLDSPFG -> FLICLQTKDKVSLFRN (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000062"
FT   VAR_SEQ         577..1476
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000063"
FT   VAR_SEQ         601..1476
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000065"
FT   MUTAGEN         508
FT                   /note="F->A,L,Q: Mildly impairs protein maturation."
FT                   /evidence="ECO:0000269|PubMed:15619636"
FT   MUTAGEN         508
FT                   /note="F->C,M: No effect on protein maturation."
FT                   /evidence="ECO:0000269|PubMed:15619636"
FT   MUTAGEN         508
FT                   /note="F->E,D,G,H,I,K,P,R,Y: Abolishes normal maturation."
FT                   /evidence="ECO:0000269|PubMed:15619636"
FT   MUTAGEN         508
FT                   /note="F->N,S,V: Nearly abolishes normal maturation."
FT                   /evidence="ECO:0000269|PubMed:15619636"
FT   MUTAGEN         508
FT                   /note="Missing: Impairs protein folding, due to small local
FT                   changes that probably disrupt crucial interactions with the
FT                   transmembrane domain. Abolishes normal maturation. Impairs
FT                   trafficking to the apical cell membrane."
FT                   /evidence="ECO:0000269|PubMed:15619636,
FT                   ECO:0000269|PubMed:21884936, ECO:0000269|PubMed:22265409"
FT   CONFLICT        20..22
FT                   /note="TTP -> STA (in Ref. 3; AAF30300)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30
FT                   /note="H -> Q (in Ref. 3; AAF30300)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410..412
FT                   /note="EKV -> QKA (in Ref. 1; AAA37417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        462
FT                   /note="S -> L (in Ref. 1; AAA37417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        623
FT                   /note="S -> T (in Ref. 1; AAA37417)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        639
FT                   /note="D -> S (in Ref. 1; AAA37417)"
FT                   /evidence="ECO:0000305"
FT   STRAND          392..400
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           405..412
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           423..425
FT                   /evidence="ECO:0007829|PDB:1R0Z"
FT   HELIX           430..435
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          439..448
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          453..459
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           464..471
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          478..483
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          488..491
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          499..501
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           502..506
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   TURN            507..509
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           514..523
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           527..530
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           536..538
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           543..545
FT                   /evidence="ECO:0007829|PDB:1R0X"
FT   HELIX           550..563
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          567..573
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           580..589
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           590..594
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   TURN            595..597
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          598..603
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           607..611
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          614..620
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          623..628
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           630..636
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           638..645
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   STRAND          647..649
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           650..652
FT                   /evidence="ECO:0007829|PDB:1R0W"
FT   HELIX           655..668
FT                   /evidence="ECO:0007829|PDB:1R0W"
SQ   SEQUENCE   1476 AA;  167870 MW;  3D1B0BBDD80C1DA8 CRC64;
     MQKSPLEKAS FISKLFFSWT TPILRKGYRH HLELSDIYQA PSADSADHLS EKLEREWDRE
     QASKKNPQLI HALRRCFFWR FLFYGILLYL GEVTKAVQPV LLGRIIASYD PENKVERSIA
     IYLGIGLCLL FIVRTLLLHP AIFGLHRIGM QMRTAMFSLI YKKTLKLSSR VLDKISIGQL
     VSLLSNNLNK FDEGLALAHF IWIAPLQVTL LMGLLWDLLQ FSAFCGLGLL IILVIFQAIL
     GKMMVKYRDQ RAAKINERLV ITSEIIDNIY SVKAYCWESA MEKMIENLRE VELKMTRKAA
     YMRFFTSSAF FFSGFFVVFL SVLPYTVING IVLRKIFTTI SFCIVLRMSV TRQFPTAVQI
     WYDSFGMIRK IQDFLQKQEY KVLEYNLMTT GIIMENVTAF WEEGFGELLE KVQQSNGDRK
     HSSDENNVSF SHLCLVGNPV LKNINLNIEK GEMLAITGST GSGKTSLLML ILGELEASEG
     IIKHSGRVSF CSQFSWIMPG TIKENIIFGV SYDEYRYKSV VKACQLQQDI TKFAEQDNTV
     LGEGGVTLSG GQRARISLAR AVYKDADLYL LDSPFGYLDV FTEEQVFESC VCKLMANKTR
     ILVTSKMEHL RKADKILILH QGSSYFYGTF SELQSLRPDF SSKLMGYDTF DQFTEERRSS
     ILTETLRRFS VDDSSAPWSK PKQSFRQTGE VGEKRKNSIL NSFSSVRKIS IVQKTPLCID
     GESDDLQEKR LSLVPDSEQG EAALPRSNMI ATGPTFPGRR RQSVLDLMTF TPNSGSSNLQ
     RTRTSIRKIS LVPQISLNEV DVYSRRLSQD STLNITEEIN EEDLKECFLD DVIKIPPVTT
     WNTYLRYFTL HKGLLLVLIW CVLVFLVEVA ASLFVLWLLK NNPVNSGNNG TKISNSSYVV
     IITSTSFYYI FYIYVGVADT LLALSLFRGL PLVHTLITAS KILHRKMLHS ILHAPMSTIS
     KLKAGGILNR FSKDIAILDD FLPLTIFDFI QLVFIVIGAI IVVSALQPYI FLATVPGLVV
     FILLRAYFLH TAQQLKQLES EGRSPIFTHL VTSLKGLWTL RAFRRQTYFE TLFHKALNLH
     TANWFMYLAT LRWFQMRIDM IFVLFFIVVT FISILTTGEG EGTAGIILTL AMNIMSTLQW
     AVNSSIDTDS LMRSVSRVFK FIDIQTEESM YTQIIKELPR EGSSDVLVIK NEHVKKSDIW
     PSGGEMVVKD LTVKYMDDGN AVLENISFSI SPGQRVGLLG RTGSGKSTLL SAFLRMLNIK
     GDIEIDGVSW NSVTLQEWRK AFGVITQKVF IFSGTFRQNL DPNGKWKDEE IWKVADEVGL
     KSVIEQFPGQ LNFTLVDGGY VLSHGHKQLM CLARSVLSKA KIILLDEPSA HLDPITYQVI
     RRVLKQAFAG CTVILCEHRI EAMLDCQRFL VIEESNVWQY DSLQALLSEK SIFQQAISSS
     EKMRFFQGRH SSKHKPRTQI TALKEETEEE VQETRL
//
